中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
7期
1-2,3
,共3页
石运生%张利民%董茂盛%贾关亮%李妍辰%张波%常美丽
石運生%張利民%董茂盛%賈關亮%李妍辰%張波%常美麗
석운생%장이민%동무성%가관량%리연신%장파%상미려
心力衰竭%cTnⅠ%NT-ProBNP%预后
心力衰竭%cTnⅠ%NT-ProBNP%預後
심력쇠갈%cTnⅠ%NT-ProBNP%예후
Congestive Heart Failure%cTnⅠ%NT-ProBNP%Prognosis
目的:探讨联合检测血浆肌钙蛋白Ⅰ(cTnⅠ)和N末端B型钠尿肽(NT-ProBNP)对心力衰竭患者预后的评估价值。方法:选择本院2012年1-11月住院的心脏病患者共161例,入院后24 h内进行cTnⅠ和NT-ProBNP同步测定。根据cTnⅠ、NT-ProBNP结果将患者分为三组吗,A组:cTnⅠ、NT-ProBNP均低于临界点;B组:cTnⅠ、NT-ProBNP其中之一高于临界点;C组:cTnⅠ、NT-ProBNP均高于临界点。出院后随访1年,指标包括心功能恶化再住院或心力衰竭恶化死亡。结果:心衰越重患者NT-ProBNP升高越明显,组间比较差异有统计学意义(P<0.01)。cTnⅠ在心功能Ⅳ级组与心功能Ⅰ、Ⅱ、Ⅲ级组比较,差异有统计学意义(P<0.05)。随访结果:B组与A组比较,再住院率差异有统计学意义(P<0.01),死亡率差异无统计学意义;C组与A组比较,再住院率差异有统计学意义(P<0.01),死亡率差异有统计学意义(P<0.01)。结论:联合检测血浆cTnⅠ和NT-ProBNP,更能准确预测心衰患者预后,对心力衰竭患者预后的评估价值更高。
目的:探討聯閤檢測血漿肌鈣蛋白Ⅰ(cTnⅠ)和N末耑B型鈉尿肽(NT-ProBNP)對心力衰竭患者預後的評估價值。方法:選擇本院2012年1-11月住院的心髒病患者共161例,入院後24 h內進行cTnⅠ和NT-ProBNP同步測定。根據cTnⅠ、NT-ProBNP結果將患者分為三組嗎,A組:cTnⅠ、NT-ProBNP均低于臨界點;B組:cTnⅠ、NT-ProBNP其中之一高于臨界點;C組:cTnⅠ、NT-ProBNP均高于臨界點。齣院後隨訪1年,指標包括心功能噁化再住院或心力衰竭噁化死亡。結果:心衰越重患者NT-ProBNP升高越明顯,組間比較差異有統計學意義(P<0.01)。cTnⅠ在心功能Ⅳ級組與心功能Ⅰ、Ⅱ、Ⅲ級組比較,差異有統計學意義(P<0.05)。隨訪結果:B組與A組比較,再住院率差異有統計學意義(P<0.01),死亡率差異無統計學意義;C組與A組比較,再住院率差異有統計學意義(P<0.01),死亡率差異有統計學意義(P<0.01)。結論:聯閤檢測血漿cTnⅠ和NT-ProBNP,更能準確預測心衰患者預後,對心力衰竭患者預後的評估價值更高。
목적:탐토연합검측혈장기개단백Ⅰ(cTnⅠ)화N말단B형납뇨태(NT-ProBNP)대심력쇠갈환자예후적평고개치。방법:선택본원2012년1-11월주원적심장병환자공161례,입원후24 h내진행cTnⅠ화NT-ProBNP동보측정。근거cTnⅠ、NT-ProBNP결과장환자분위삼조마,A조:cTnⅠ、NT-ProBNP균저우림계점;B조:cTnⅠ、NT-ProBNP기중지일고우림계점;C조:cTnⅠ、NT-ProBNP균고우림계점。출원후수방1년,지표포괄심공능악화재주원혹심력쇠갈악화사망。결과:심쇠월중환자NT-ProBNP승고월명현,조간비교차이유통계학의의(P<0.01)。cTnⅠ재심공능Ⅳ급조여심공능Ⅰ、Ⅱ、Ⅲ급조비교,차이유통계학의의(P<0.05)。수방결과:B조여A조비교,재주원솔차이유통계학의의(P<0.01),사망솔차이무통계학의의;C조여A조비교,재주원솔차이유통계학의의(P<0.01),사망솔차이유통계학의의(P<0.01)。결론:연합검측혈장cTnⅠ화NT-ProBNP,경능준학예측심쇠환자예후,대심력쇠갈환자예후적평고개치경고。
Objective:To explore the assessed value of combined detection of cTn Ⅰ and NT-ProBNP on the Congestive Heart Failure(CHF). Method:161 inpatients with CHF attended our hospital from Jan. 2012 to Nov. 2012 were simultaneous measured cTnⅠand NT-ProBNP within 24 hours after being hospitalized. 161 patients were divided into three groups according to the result:A group( both the content of cTnI and NT-ProBNP were less than cut off point );B group(either cTn Ⅰor NT-ProBNP was higher than cut off point);C group(both cTn Ⅰand NT-ProBNP were higher than cut off point ). Patients had been followed up one year since they were out of the hospital,which indices including re-hospitalization caused by cardiac function becoming worse or death caused by CHF. Result:The worse CHF was,the higher the content of NT-ProBNP was(P<0.01). There was significant statistic difference between the heart function gradeⅣand gradeⅠ,Ⅱ,Ⅲin aspect of the content of cTnⅠ(P<0.05). Result of following up:there was significant difference between the group B and group A in terms of re-hospitalization rate A(P<0.01),but no in death rate(P>0.05). While there were significant difference between the group C and group A in terms of both re-hospitalization rate and death rate(P<0.01). Conclusion:Combined detection of plasma cTnⅠand NT-ProBNP could best predict the prognosis of patient with CHF with higher assessment value.